Add Formweb to your mobile device
Approved Formulary
Search results for:
icatibant
icatibant
- Restricted Medications Non-Formulary / Non-Stocked
Brand names: Firazyr
No brands, forms, or strengths have been added for this generic.
Display Complement Inhibitors Class:
923200
Medication comments:
| Per policy, these hazardous drugs have special waste requirements. | |
|---|---|
| Generic (Brand) | Waste Requirements |
| icatibant (Firazyr) | Hazardous Waste ⇒ BLACK BUCKET |
| USP <800> Hazardous Drugs | ||||||
|---|---|---|---|---|---|---|
| Per Policy, these drugs have special handling requirements (any drug with an "AOR" is exempt from these requirements under normal circumstances). | ||||||
| generic (Brand) Route | Relative Risk Level | AOR? | NIOSH 2024 Table | MSHI?↑ | Warnings | |
| icatibant (Firazyr) SQ | Low | N/A | 2B↑ | |||
| NIOSH Supplemental information (2016): in laboratory studies, premature birth and abortion rates increased at a dose that was less than 1/40th the MRHD, and delayed parturition and fetal death occurred at 0.5 and 2-fold, respectively, the MRHD FDA Pregancy Category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks; | ||||||
Last updated: May. 29, 2025
- Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug
- Hazardous Waste BLACK BUCKET